Om

Alzai Health Corp. is a healthcare technology company focused on AI-driven disease risk screening. Its current products center on non-invasive tools that analyze routine, pre-existing medical data to identify individuals at elevated risk of Alzheimer’s disease, related dementias, and other conditions before clinical diagnosis. The platform is designed to support earlier detection, risk stratification, timely intervention, and prevention-oriented care within existing healthcare workflows. Alzai Health Corp. serves healthcare providers, payors, pharmaceutical companies, clinical research organizations, and public health stakeholders that need scalable screening capabilities for population-level disease management. Based in Toronto, Canada, the company operates in the biotechnology and digital health space, where its solutions are positioned to complement electronic medical records and broader healthcare infrastructure.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I ALZAI HEALTH MED ENDAVU: Køb Alzai Health ($H2F) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Alzai Health, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.